What the world's religions teach, applied to vaccines and immune globulins.

For thousands of years, humans have sought objectives, relief, values, understanding and fellowship in religious practice. More than 1000 years ago, Buddhist nuns changed small pox. Since Jenner began vaccinating the smallpox vaccine in 1796, several people opposed and refused immunization for various religious reasons. In this article we outline the classics of this interpretation, the basis of norms, and the paragraph that supports vaccination. Consider a population-rich tradition of population including Hinduism, Buddhism, Jainism, Judaism, Christianity, Islam. Subjects of interest such as blood components, pharmaceutically acceptable excipients from swine or bovine, rubella strain RA 27/3, and cell culture medium with remote fetal origin are evaluated for the identified religious problems . In this review, more than 60 reports or evaluations on the occurrence of vaccine-preventable infections within religious communities or from religious communities to broader communities were identified. In many cases, rejection of vaccination against vaccination actually reflects concern about personal beliefs in the social network of people around the safety or faith group of the vaccine rather than the theological objection itself doing. Topics useful for vaccination include the conversion of vaccine excipients from their raw materials, extensive dilution of the desired components, immunological medical objectives (as opposed to diet), and alternative methods Missing is included. Other important functions include the need to protect health and community obligations (eg, parents, neighbors) and so on. Focusing on "temples without body contamination" contrasts with other educational and quality control requirements for making vaccines and immunoglobulins. Medical professionals providing advice to ambiguous patients and guardians ask about the basis of concerns and how individuals apply religious understanding in the determination of medical products and explain the facts about content and processes , We can propose further dialogue with knowledgeable religious leaders. Please explain the important considerations of observing believers in all population-rich religions

People who are allergic to vaccine ingredients or who are less than 6 months must receive immunoglobulin (IG) once. Based on the dose given, immunoglobulins provide effective protection up to 2 months against hepatitis A virus infection. If you are staying for more than two months, you can take IG once more to continue protection.

Post-exposure prophylaxis (PEP) refers to an attempt to prevent or treat a disease after exposure. In case of hepatitis A, post-exposure prophylaxis is injection of hepatitis A vaccine or immunoglobulin. However, vaccines or immunoglobulins are effective in preventing hepatitis A only during the first two weeks after exposure. People who have not been vaccinated recently (within two weeks) exposed to hepatitis A virus should be vaccinated with hepatitis A vaccine or injected with immunoglobulin to prevent serious illness . To treat the symptoms of hepatitis A, physicians usually recommend rest, adequate nutrition and moisture. Some people need medical care at hospitals. Patients with hepatitis A may take months to feel better

Those planning to travel to countries that have not received hepatitis A vaccination or have not suffered from hepatitis A need to vaccinate hepatitis A vaccine or immunoglobulin (IG) before travel there is. Even in countries with common hepatitis A, tourist resorts and luxury hotel travelers are facing high risk. Even travelers, when traveling to countries where hepatitis A is common, they maintain good hand hygiene and report that they are cautious about what they eat and drink.

Those planning a trip to an epidemic should vaccinate hepatitis A vaccine or immunoglobulin before departure. Hepatitis A vaccination can be done to anyone over 2 years old and has the advantage of providing long term preventive measures (at least 20 years old). A hepatitis A vaccine is an inactivated HAV formulation, and in vaccine recipients with over 90% vaccine recipients, a protective anti HAV level can be obtained within 30 days of the first dose. The hepatitis A vaccine approved in the US is equivalent in potency, including Havrix® (Glaxo SmithKline), VAQTA® (Merck & Co.) and Twinrix® (combination vaccine of hepatitis A and B, Glaxo) For Havrix (R) and VAQTA (R), vaccination is done in a two-dose regimen (0, 6 months), Twinrix (TM) is scheduled for 3 doses (0, 1 , 6 months). Provide a second (or third) dose to ensure the protection of those who do not respond to the first vaccination